Literature DB >> 21873209

Transcription factor RBPJ/CSL: a genome-wide look at transcriptional regulation.

Lucio Miele1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21873209      PMCID： PMC3169161          DOI： 10.1073/pnas.1110570108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  19 in total

1.  Nuclear localization of CBF1 is regulated by interactions with the SMRT corepressor complex.

Authors:  S Zhou; S D Hayward
Journal:  Mol Cell Biol       Date:  2001-09       Impact factor: 4.272

2.  Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association.

Authors:  S Harada; R Yalamanchili; E Kieff
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

Review 3.  Epstein-Barr virus (EBV) and its associated human cancers--genetics, epigenetics, pathobiology and novel therapeutics.

Authors:  Qian Tao; Lawrence S Young; Ciaran B J Woodman; Paul G Murray
Journal:  Front Biosci       Date:  2006-09-01

4.  Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA.

Authors:  Jeffrey J Wilson; Rhett A Kovall
Journal:  Cell       Date:  2006-03-10       Impact factor: 41.582

5.  Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells.

Authors:  Hongfang Wang; James Zou; Bo Zhao; Eric Johannsen; Todd Ashworth; Hoifung Wong; Warren S Pear; Jonathan Schug; Stephen C Blacklow; Kelly L Arnett; Bradley E Bernstein; Elliott Kieff; Jon C Aster
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-07       Impact factor: 11.205

6.  Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2.

Authors:  J J Hsieh; T Henkel; P Salmon; E Robey; M G Peterson; S D Hayward
Journal:  Mol Cell Biol       Date:  1996-03       Impact factor: 4.272

7.  Epstein-Barr virus exploits intrinsic B-lymphocyte transcription programs to achieve immortal cell growth.

Authors:  Bo Zhao; James Zou; Hongfang Wang; Eric Johannsen; Chih-wen Peng; John Quackenbush; Jessica C Mar; Cynthia Casson Morton; Matthew L Freedman; Stephen C Blacklow; Jon C Aster; Bradley E Bernstein; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-11       Impact factor: 11.205

Review 8.  Both Epstein-Barr viral nuclear antigen 2 (EBNA2) and activated Notch1 transactivate genes by interacting with the cellular protein RBP-J kappa.

Authors:  L J Strobl; H Höfelmayr; C Stein; G Marschall; M Brielmeier; G Laux; G W Bornkamm; U Zimber-Strobl
Journal:  Immunobiology       Date:  1997-12       Impact factor: 3.144

9.  Structural basis for cooperativity in recruitment of MAML coactivators to Notch transcription complexes.

Authors:  Yunsun Nam; Piotr Sliz; Luyan Song; Jon C Aster; Stephen C Blacklow
Journal:  Cell       Date:  2006-03-10       Impact factor: 41.582

10.  Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation.

Authors:  Chih-Wen Peng; Yong Xue; Bo Zhao; Eric Johannsen; Elliott Kieff; Shizuko Harada
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-19       Impact factor: 11.205
View more
  14 in total

Review 1.  Contextual Regulation of Skeletal Physiology by Notch Signaling.

Authors:  Daniel W Youngstrom; Kurt D Hankenson
Journal:  Curr Osteoporos Rep       Date:  2019-08       Impact factor: 5.096

2.  Quantitative analysis of the bidirectional viral G-protein-coupled receptor and lytic latency-associated nuclear antigen promoter of Kaposi's sarcoma-associated herpesvirus.

Authors:  Isaac B Hilton; Dirk P Dittmer
Journal:  J Virol       Date:  2012-06-27       Impact factor: 5.103

Review 3.  Transcription factors, transcriptional coregulators, and epigenetic modulation in the control of pulmonary vascular cell phenotype: therapeutic implications for pulmonary hypertension (2015 Grover Conference series).

Authors:  Soni S Pullamsetti; Frédéric Perros; Prakash Chelladurai; Jason Yuan; Kurt Stenmark
Journal:  Pulm Circ       Date:  2016-12       Impact factor: 3.017

Review 4.  Epigenetic mechanisms in cancer: push and pull between kneaded erasers and fate writers.

Authors:  Ammad Ahmad Farooqi; Jen-Yang Tang; Ruei-Nian Li; Muhammad Ismail; Yung-Ting Chang; Chih-Wen Shu; Shyng-Shiou F Yuan; Jing-Ru Liu; Qaisar Mansoor; Chih-Jen Huang; Hsueh-Wei Chang
Journal:  Int J Nanomedicine       Date:  2015-04-24

5.  EBNA2 Drives Formation of New Chromosome Binding Sites and Target Genes for B-Cell Master Regulatory Transcription Factors RBP-jκ and EBF1.

Authors:  Fang Lu; Horng-Shen Chen; Andrew V Kossenkov; Karen DeWispeleare; Kyoung-Jae Won; Paul M Lieberman
Journal:  PLoS Pathog       Date:  2016-01-11       Impact factor: 6.823

6.  The dual nature of Notch in tissue homeostasis and carcinogenesis.

Authors:  Joseph M Valdez; Li Xin
Journal:  Cell Cycle       Date:  2013-01-31       Impact factor: 4.534

7.  Cis-regulatory complexity within a large non-coding region in the Drosophila genome.

Authors:  Mukta Kundu; Alexander Kuzin; Tzu-Yang Lin; Chi-Hon Lee; Thomas Brody; Ward F Odenwald
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

Review 8.  Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition.

Authors:  Ingrid Espinoza; Radhika Pochampally; Fei Xing; Kounosuke Watabe; Lucio Miele
Journal:  Onco Targets Ther       Date:  2013-09-06       Impact factor: 4.147

Review 9.  Notch Signaling in Neuroendocrine Tumors.

Authors:  Judy S Crabtree; Ciera S Singleton; Lucio Miele
Journal:  Front Oncol       Date:  2016-04-14       Impact factor: 6.244

10.  EBF1 binds to EBNA2 and promotes the assembly of EBNA2 chromatin complexes in B cells.

Authors:  Laura V Glaser; Simone Rieger; Sybille Thumann; Sophie Beer; Cornelia Kuklik-Roos; Dietmar E Martin; Kerstin C Maier; Marie L Harth-Hertle; Björn Grüning; Rolf Backofen; Stefan Krebs; Helmut Blum; Ralf Zimmer; Florian Erhard; Bettina Kempkes
Journal:  PLoS Pathog       Date:  2017-10-02       Impact factor: 6.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.